Results for tag: "Mircera"

Mircera is a cardiovascular drug used to treat anemia in patients with chronic kidney disease. It is a recombinant form of erythropoietin, a hormone that stimulates the production of red blood cells. Mircera is administered by subcutaneous injection and is available in both pre-filled syringes and vials. It is used to reduce the need for blood transfusions and to improve quality of life in patients with anemia. Mircera is marketed by Roche, a Swiss multinational healthcare company. Other companies in the market include Novartis, Amgen, and Pfizer. These companies are involved in the development, manufacture, and marketing of Mircera and other cardiovascular drugs. Show Less Read more